Showing results (531-540 of 565) with videos related to
Sort By:
Pageof 57
Space Science Reviews|December 22, 2023
The Lucy Thermal Emission Spectrometer (L'TES) InstrumentP R Christensen, V E Hamilton, G L Mehall, et al.BMC Cancer|November 15, 2011
Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescenceGeorgina Hernandez-Flores, Pablo C Ortiz-Lazareno, Jose Manuel Lerma-Diaz, et al.Archives of Medical Research|November 9, 2000
Update in internal medicineF López-Jiménez, M Brito, Y W Aude, et al.Global Change Biology|September 3, 2014
Anticipative management for coral reef ecosystem services in the 21st centuryAlice Rogers, Alastair R Harborne, Christopher J Brown, et al.Annals of the Rheumatic Diseases|December 25, 2015
Proteinase-activated receptor 2 modulates OA-related pain, cartilage and bone pathologyCarmen Huesa, Ana C Ortiz, Lynette Dunning, et al.Chemical Communications (Cambridge, England)|May 24, 2012
Tuning glycosidase inhibition through aglycone interactions: pharmacological chaperones for Fabry disease and GM1 gangliosidosisM Aguilar-Moncayo, T Takai, K Higaki, et al.Transplantation Proceedings|December 23, 2018
Predicting Short- and Long-Term Outcomes in Adult Heart Transplantation: Clinical Utility of MELD-XI ScoreC Ortiz-Bautista, M D García-Cosio, D Lora-Pablos, et al.Biological Research|December 25, 2021
Effects of enriched-potassium diet on cardiorespiratory outcomes in experimental non-ischemic chronic heart failureKarla G Schwarz, Katherin V Pereyra, Camilo Toledo, et al.Journal of Experimental & Clinical Cancer Research : CR|December 22, 2011
MEIS1, PREP1, and PBX4 are differentially expressed in acute lymphoblastic leukemia: association of MEIS1 expression with higher proliferation and chemotherapy resistanceJudith A Rosales-Aviña, Jorge Torres-Flores, Adriana Aguilar-Lemarroy, et al.Clinical and Experimental Immunology|December 11, 2020
Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axisF Solorzano-Ibarra, A G Alejandre-Gonzalez, P C Ortiz-Lazareno, et al.Pageof 57